American Well Corp logo

American Well Corp(AMWL)

upturn advisory logo
ADVISORIES YOU CAN VERIFY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 56 days
PROFIT SINCE LAST BUY
+45.08%
LAST CLOSE
$13.42
09/21/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close

Advisory Performance History (Simulated)Advisory Performance History info

Upturn Advisory & Investor View for AMWL

09/21/2026: AMWL (1-star) has a low Upturn Star Rating. Not recommended to BUY.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -34.77%
Avg. Invested days 29
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 09/21/2026

Upturn Scorecard

Upturn Star Rating

AMWL receives a 3-star rating, supported by available scored pillars. The rating is constrained by weak unit economics, and limited analyst upside.

Company Fundamentals

AMWL has moderate overall fundamentals (3 stars), with soft financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+54.0%) is partially offset by soft cash generation (FCF margin -26.5%), slightly negative revenue growth (-2.0%), soft profitability (net margin -38.4%).

Financial Health Rating

AMWL's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 53.6%). Operating efficiency is soft (2 stars), which helps explain the 2-star overall score.

Growth Momentum Score

Earnings growth is AMWL's strongest growth driver at +54.0% FY2025 versus FY2024 (strong, 5 stars). By comparison, free-cash-flow growth (+53.7%, strong) is also strong, while revenue growth (-2.0%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

Institutional ownership is 50.8% and approximately 79.2% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 5.39% supports management-shareholder alignment.

Top 5 Institutional Investors

Morgan Stanley - Brokerage Accounts 6.80%
RIMA MANAGEMENT, LLC 6.68%
Cable Car Capital LLC 5.89%
Vanguard Capital Management, LLC 3.34%
Acadian Asset Management LLC 2.39%

Unit Economics (Per $1K Revenue)

AMWL generates approximately $533 of gross profit, $-422 of operating income, and $-265 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong cash conversion and healthy margins support the rating, although capital efficiency remains below the highest tier.

Economic Dimensions

Effective Tax Rate: -0.46% (Tax Credit)

Quantitative Style Profile

AMWL has a liquid profile. Elevated volatility is the primary drawback.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 229.74M USD
Price to earnings Ratio -
1Y Target Price 12.8
Price to earnings Ratio -
1Y Target Price 12.8
Volume (30-day avg) 98.1K shares
Beta 1.71
52 Weeks Range 3.71 - 14.19
Updated Date 09/20/2026
52 Weeks Range 3.71 - 14.19
Updated Date 09/20/2026
Dividends yield (FY) -
Basic EPS (TTM) -4.78

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Advertisement

Valuation

Trailing PE -
Forward PE -
Enterprise Value 40.90M
Price to Sales(TTM) 1.07
Enterprise Value 40.90M
Price to Sales(TTM) 1.07
Enterprise Value to Revenue 0.19
Enterprise Value to EBITDA -0.82
Shares Outstanding 15.06M
Shares Floating 11.93M
Shares Outstanding 15.06M
Shares Floating 11.93M
Percent Insiders 5.39
Percent Institutions 50.8

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

About American Well Corp

Exchange NYSE
Headquarters Boston, MA, United States
IPO Launch date 2020-09-17
Chairman & CEO Dr. Ido Schoenberg M.D.
Sector Healthcare
Industry Health Information Services
Full time employees 562
Full time employees 562

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.